Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space ...

GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer and UCB. The departures coincided with ...

The company ended the quarter with $192 million in cash and equivalents, enough to fund operations past 2027. 2seventy Bio ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

MEMS, wearable/implantable electronics and bio-tissue therapeutics, the pursuit of piezoelectric biomaterials has become a ...

Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A ...

MORE: Jake Paul has released the beast in Mike Tyson. Who is Jake Paul's girlfriend Jutta Leerdam? Turning pro in 2018, ...

Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is ...

Bio-based materials may pose a greater health risk to some of the planet's most important species than the conventional ...

bluebird bio BLUE is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement. Analysts estimate that bluebird bio will ...

Kronos Bio, Inc. (KRON) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.54 per share a year ago. These figures are ...

Evogene (EVGN) subsidiary Lavie Bio announced the commercial expansion of Yalos seed-treatment to soybean, following successful field trials ...